Sleep
Ashwagandha Side Effects: Liver, Thyroid, Pregnancy and Where the UK Stands
How we grade ›Sources checked on Our independence ›
We may earn a commission if you buy through our links. How we choose ›
Quick answer
Most people in short trials report few side effects, mainly stomach upset at high doses, but rare cases of liver injury have been linked to ashwagandha, and it can raise thyroid hormone levels. The UK Food Standards Agency advises that pregnant women and people with liver conditions avoid ashwagandha supplements while its safety review continues, and Denmark banned it in food supplements in 2023. If you have a thyroid, autoimmune or liver condition, or take regular medication, speak to a GP or pharmacist first.
Who should avoid it: Pregnant people and people with liver disease should avoid ashwagandha supplements under the FSA interim advice reported by Which?. Which? and France's ANSES also flag thyroid and autoimmune conditions and regular medication. ANSES additionally lists breastfeeding women, heart conditions, sedatives and under-18s. Speak to a GP or pharmacist before deciding whether to take it.
Common side effects in trials
LiverTox says side effects are uncommon, but large doses can lead to stomach upset, diarrhoea, nausea and vomiting. Trials did not report liver enzyme rises or serious adverse events. That does not rule out uncommon reactions or establish long-term effects: Which? says studies typically lasted 8 to 12 weeks, used 300 to 600 mg of standardised root extract, often involved fewer than 100 people and were often funded by extract makers.
Ashwagandha liver injury: reports, symptoms and what to do
LiverTox records liver injury reports from 2017 and a 2024 review counting 23 clinically apparent cases. Symptoms typically appeared 2 to 12 weeks after starting, with jaundice and itching. Most reported cases were mild to moderate and resolved within 1 to 4 months after stopping, but fatal liver failure and rare emergency transplants have been described, mainly in people with existing liver disease or cirrhosis. The number of reports does not tell us the risk per user.
LiverTox assigns likelihood score B, meaning likely involvement in clinically apparent liver injury. Some products may be mislabelled or contaminated, but several tested products contained only ashwagandha. Separately, the FSA told Which? it could not yet say whether a direct link exists between ashwagandha and liver injury. These statements come from different assessments and should not be presented as a settled UK finding.
A July 2026 report of Australia's TGA update describes a very rare liver-injury warning: 11 possible reports, six with no other likely contributing ingredient, including two needing hospital care. No Australian deaths or transplants were reported in that update. These counts must not be added to the LiverTox total because overlap is unknown.
Stop and seek medical advice if your skin or eyes turn yellow or you develop persistent itching. Do not restart after a suspected liver reaction. The NHS Specialist Pharmacy Service recommends reporting new or worsening symptoms to your healthcare practitioner and the MHRA Yellow Card scheme. Its page is general complementary-product advice, not an ashwagandha-specific assessment.
Ashwagandha and thyroid hormones
A 2018 double-blind pilot trial in 50 adults with subclinical hypothyroidism compared 600 mg root extract daily with placebo for eight weeks. TSH, T3 and T4 changed significantly compared with placebo. This single-centre pilot shows measurable hormonal effects; it is not advice to treat a thyroid condition with a supplement. LiverTox also describes a 2005 thyrotoxicosis case that resolved after stopping. Ask your GP if you have a thyroid condition or take thyroid medication.
Pregnancy, breastfeeding and hormones
The FSA interim advice reported by Which? is to avoid ashwagandha supplements during pregnancy. Which? reports concern about very high doses and inadequate evidence at lower doses. France's ANSES advises avoidance during pregnancy and breastfeeding, and in hyperandrogenism. If pregnant, trying to conceive or breastfeeding, discuss supplements with a GP or pharmacist rather than using a trial dose as reassurance.
Autoimmune conditions and medicine interactions
Which? flags possible worsening of autoimmune conditions such as lupus, multiple sclerosis or rheumatoid arthritis. ANSES flags people taking sedatives and those with thyroid, liver or heart conditions. If you take regular medicines or have an autoimmune condition, check with a GP or pharmacist first. The cited sources do not establish a complete list of interactions or a suitable dose for these groups.
Is ashwagandha banned in the UK or elsewhere?
The FSA's June 2026 summary says its 2024 call for evidence received 19 responses for the Committee on Toxicity's risk assessment. That page announces no restrictions. Which? reports no authorised ashwagandha health claims in the UK. The cited regulatory review reports no UK ban, with the assessment pending.
| Country | Position described in the cited sources |
|---|---|
| UK | No ban reported; Committee on Toxicity assessment pending |
| Denmark | Banned in food supplements in 2023 following a DTU risk assessment |
| Sweden | Danish assessment applied, with municipalities deciding case by case |
| Netherlands | RIVM advised against use in March 2024; a 2025 proposed supplement ban was not an enacted ban in the review |
| France | ANSES avoidance advice for specified groups, not a ban |
| Germany | BfR recommended EU-level restrictions and avoidance for specified groups |
| Australia | Mandatory pregnancy warning on medicines following a 2020 review; separate July 2026 liver warning reported above |
Date limitation: the 2025 regulatory review covers data to late 2024. Check current status before relying on overseas rules; a proposal is not a ban. Denmark's assessment could not determine a suitable intake level.
For balance, a 2024 editorial disputes Denmark's assessment, arguing it was not peer reviewed and overlooked benefits. Two contributors disclose links to ashwagandha research or the World Ashwagandha Council. This is an editorial with declared interests, not a new clinical trial or proof that rare reactions cannot occur.
What does the sleep evidence show?
A 2021 systematic review pooled five randomised trials with 400 adults. It found a small significant improvement in overall sleep, with standardised mean difference -0.59. Effects were larger in participants with insomnia, at 600 mg/day or more and after eight weeks or longer. Those are study findings, not dosing advice. No serious side effects were reported, but the authors said serious-adverse-effect data were limited and more long-term data were needed.
Our grade: Early research for sleep. We assess the sleep evidence as moderate-low certainty; on our four-label scale, the small trials and limited long-term data fit Early research. Benefits and adverse-reaction reports answer different questions. We do not recommend starting ashwagandha on the strength of this sleep evidence alone. Compare our sleep supplement guide and longevity supplement evidence guide.
If you take it: practical precautions
- Check with a GP or pharmacist first if pregnant, trying to conceive, breastfeeding, taking regular medicines or living with a liver, thyroid or autoimmune condition.
- Stop and seek medical advice for jaundice or persistent itching; report suspected side effects through Yellow Card.
- Do not restart after a suspected liver reaction.
- Which? advises transparent brands and root rather than leaf extract; the reported TGA update advises against unregulated online buying. These precautions do not remove the uncertainty.
This is general information for discussing a decision with a GP or pharmacist, not a diagnosis or a clinical recommendation.
Frequently asked questions
Is ashwagandha banned in the UK?
+
No. It is legal as a food supplement, but the FSA is reviewing its safety and advises pregnant women and people with liver conditions to avoid it (Which?; FSA). Denmark banned it in supplements in 2023 (Brendler 2025).
Can ashwagandha damage your liver?
+
Rarely. Cases are usually mild to moderate and resolve 1 to 4 months after stopping, but severe cases have occurred, mainly in people with existing liver disease (LiverTox).
Does ashwagandha affect the thyroid?
+
It changed TSH, T3 and T4 in an 8-week trial (Sharma 2018), so speak to your GP if you have a thyroid condition or take thyroid medication.
Can I take ashwagandha while pregnant?
+
The FSA advises pregnant women to avoid it (Which?).
What are the common side effects?
+
Uncommon in trials; high doses can lead to stomach upset, diarrhoea, nausea and vomiting (LiverTox).
How long do trials last?
+
Typically 8 to 12 weeks at 300 to 600 mg of root extract; long-term effects are not established (Which?).
Last updated










